• Synthesis-driven medicinal chemistry emerges as the dominant pattern, with development of new routes to bioactive molecules, including dipeptide derivatives, cystin, hydantoins, and related motifs, enabling exploration of pharmacophores [8], [10], [11], [12], [13].

• Early stereochemical emphasis shapes pharmacology: extensive focus on optical activity and enantioselective transformations in amino acids, dipeptides and diketopiperazines, presaging structure-activity considerations [6], [7], [9], [10].

• Natural product/phytochemical analytics dominate pharmacological inquiry: iron-chloride colorimetric tests for tannins/phenolics, phytotherapy studies, and phytochemical interactions with bioactive compounds [3], [14], [15], [20].

• Enzyme inhibition and target-based pharmacology emerge as a recurring motif: enzyme-inhibition concepts appear in diketopiperazine work and acylderivative rearrangements, signaling early molecular targeting approaches [4], [9], [12], [20].